MaureenMeganO'BrienMD(She/Her)
Pediatric Hematology & Oncology • Aurora, COPediatric Hematologic Oncology
Professor, University of Colorado School of Medicine, Children's Hospital Colorado
Dr. O'Brien is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13123 East 16th Avenue
Box B115
Aurora, CO 80045Phone+1 720-777-6863Fax+1 720-777-7227
Education & Training
Stanford University School of MedicineMS, Epidemiology, 2007 - 2008
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 2004 - 2007
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2000 - 2003
Harvard Medical SchoolClass of 2000- Harvard UniversityAB, Biochemical Sciences, Summa Cum Laude, 1992 - 1996
Certifications & Licensure
CA State Medical License 2004 - Present
CO State Medical License 2023 - 2025
KY State Medical License 2021 - 2024
OH State Medical License 2009 - 2024
IN State Medical License 2021 - 2023
MA State Medical License 2003 - 2005- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Apr 14
- Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma Start of enrollment: 2012 Aug 01
- A Safety Study of SGN-CD19A for Leukemia and Lymphoma Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 42 citationsPrecursor B‐cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosisMaureen M. O'Brien, YoungNa Lee-Kim, Tracy I. George, Kenneth L. McClain, Clare J. Twist
Pediatric Blood & Cancer. 2008-02-01 - 384 citationsPhase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaArend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, Rupert Handgretinger, Tanya M. Trippett
Journal of Clinical Oncology. 2016-10-03 - 53 citationsBortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology GroupTerzah M. Horton, James A. Whitlock, Xiaomin Lu, Maureen M. O'Brien, Michael J. Borowitz
British Journal of Haematology. 2019-07-01
Abstracts/Posters
- Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid...Maureen M O'Brien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)Maureen M O'Brien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute LeukemiaMaureen M O'Brien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
